Micron develops pharmaceutical products, based on its proprietary microneedle patch technology, that are designed to provide enhanced vaccines and proprietary drugs efficacy, superior patient compliance, and simplified administration, distribution, and storage logistics.
The benefits of Micron’s microneedle patch technology stem from its proprietary design and manufacturing which allow for:
Micron has assembled a team of scientists and engineers with medical device, biopharmaceutical, analytical, quality, and cGMP manufacturing experience who work in state-of-the art facilities that include wet laboratory and cleanroom space. Micron works with a network of consultants and CROs to define and execute regulatory strategies, including preclinical and clinical studies.
Micron’s capabilities include: